Abstract
1281
Learning Objectives 1. To present diagnostic performance of PET/CT for detecting and characterizing various malignant and benign complications in patients with HIV/AIDS. 2. To discuss new and evolving horizons related to molecular imaging and their potential in the management of HIV/AIDS patients.
PET/CT has been widely employed for assessing malignancies that are associated with HIV infected patients for diagnosis, staging and detection of metastasis and treatment monitoring. Opportunistic infections are common in HIV patients, and again, PET can aid in diagnosing and distinguishing benign diseases from superimposed malignancies. Thus, PET can lead to adapting appropriate treatment and decrease the need for invasive biopsies. In addition, PET/CT can be used for monitoring response to highly active antiretroviral therapy. In this presentation, the following subjects will be reviewed: 1. Applications in malignancy a. Kaposi Sarcoma b. HPV related malignancies c. Lymphoma 2. Applications in benign complications a. Opportunistic infection b. CNS complications / dementia c. Assessment of treatment d. Fever of unknown origin e. Cardiovascular risk assessment